drugset / Trial / NCT00148421

Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

NCT00148421

Phase 3 Completed Amgen
RandomizedParallel-groupOpen-labelTreatment

Summary

Comparing two drugs to treat subjects with non-myeloid malignancies receiving multicycle chemotherapy.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Darbepoetin alfa Protein / enzyme biologic 200 ug
Subject epoetin alfa Protein / enzyme biologic 40000 iu

Indications